SUPPLEMENTARY TEXT:
Supplementary Text 1: Current mimicry-by-methylation approaches for RM systems.
Numerous approaches have been developed in attempts to overcome the restriction-modification (RM) 1 barriers and each of these provides evidence that circumvention of RM systems can lead to genetic 2 tractability in bacteria (1) (2) (3) (4) (5) (6) (7) (8) (9) . These can all be referred to as mimicry-by-methylation approaches, as they 3 essentially seek to modify the methylation pattern of a genetic tool to match the desired host and achieve 4 molecular mimicry. Such approaches can be categorized as either unrefined or sophisticated, and each has 5 a distinct disadvantage (10), including being arduous, resource intensive, or requiring many years to 6 develop. Once developed, these typically suffer from limited applicability across different strains (11). 7
There are three common unrefined approaches. (A) Randomly mutagenize entire populations of a 8 genetically intractable bacterial strain with ultraviolet radiation or chemicals, and then select for restriction-9 deficient mutants with increased transformation efficiency (12, 13). Although random mutagenesis may 10 generate genetically tractable mutants, it also generates additional undefined mutations, such that 11 genetically tractable mutants are no longer a good model of the original strain (14). (B) Mix plasmid DNA 12 with a crude cell extract from the strain of interest so that the strains' innate MTases methylate (protect) 13 targets present on the plasmid, thus marking them as self-DNA (15). (C) Expose the target bacterium to a 14 nonlethal heat treatment before transformation to temporarily inhibit restriction enzyme activity (9, 16, 17).
15
Neither heat-nor crude extract-treatments are reproducible, and both have limited effectiveness among 16 most strains (3, 17). 17
There are two common sophisticated approaches. (A) Methylate target sites on tools by using in vitro 18 methylation with either recombinant MTases (15, 18) or commercially available MTase enzymes (19), 19 which are currently available for only 37 of >450 known targets (20) . (B) Alternatively, achieve in vivo 20 methylation by passaging a plasmid through a related strain that is either restriction enzyme deficient (21) 21 or engineered to generate the methylation profile of the strain of interest, i.e., the plasmid artificial 22 modification (PAM) technique (22) . Although the PAM approach is useful in some strains, inherent 23 complications prevent its widespread application. These include; a) the exact genetic loci and accessory 24 open reading frames (ORFs) for most RM systems are poorly defined and therefore cannot be introduced 25 into E. coli PAM hosts without extensive trial and error (23); b) many MTases cannot be cloned functionally 26 in the absence of their REase partner or are difficult to clone in E. coli due to differences in promoter 27 structure, GC content, codon usage, or host-toxicity; and c) many bacteria have multiple active RM systems 28 and multilayered methylated signatures that become difficult to effectively recapitulate in vitro, i.e., it is 29 impractical to clone several functional MTase enzymes within a single E. coli PAM host for each new 30 bacterial strain of interest. 31
Supplementary Text 2: Coining the term 'SyngenicDNA'. 32
SyngenicDNA is an intentionally broad term. The word syngenic (also syngeneic) is used in immunology 33 to mean sufficiently identical and immunologically compatible as to allow for transplantation without 34
provoking an immune response. It is usually applied in the context of eukaryotic cell or tissue 35 transplantation in cases where the donor and the recipient are identical twins(24). Syngenic transplants are 36 the easiest because the identical recipient's immune system readily accepts the graft without risk of 37 rejection. Accordingly, we coined the term 'SyngenicDNA' and define it as a piece of synthetic DNA that 38 has been engineered with sufficient sequence and epigenetic compatibility to allow it to function as self 39 within a specific bacterial host, upon artificial transformation, and be accepted by its RM defenses, i.e., the 40 bacterial innate immune system (25). 41
Supplementary Text 3: Identification of RM system target motifs. 42
Post-replicative modification of DNA by MTases in bacteria results in three types of epigenetic markers: 43 N6-methyladenine (m6A), N4-methylcytosine (m4C), and 5-methylcytosine (m5C) (23). The complete set 44 of methylations across a bacterial genome is termed the methylome. Currently, efficient methylome analysis 45 can only be accomplished by using single molecule real-time sequencing (SMRTseq; www.pacb.com) (26).
46
During SMRTseq, a polymerase adds fluorescently labelled bases to a DNA template while the sequencing 47 instrument records both the sequence of bases added and the kinetic information (milliseconds) between 48 successive additions, forming a sequencing trace. DNA templates containing a methylated base cause the 49 polymerase to stall at those sites, leading to a delay in the sequence trace. This kinetic information is used 50 to identify the specific sites of methylation in genomic DNA (m6A, m4C or m5C) based on their 51 characteristic trace (26). SMRTseq analysis software summarizes the exact sequence of the methylated 52 motifs, the number of motifs present on the genome and the percentage of motifs that are methylated. 53 Accordingly, during the target identification step within the SyngenicDNA approach, we use SMRTseq-54 generated methylome data to identify active RM systems and then infer the specific target recognized by 55 the REase of each system. In a bacterial genome, a methylated motif represents either A) an RM system's 56 target recognition sequence methylated by an MTase to protect the site from its cognate REase, or B) a 57 modification introduced by an orphan MTase, which lacks a cognate REase and may be involved in 58 regulatory activity (27) . To differentiate between these two possibilities, we first evaluate the quantitative 59
SMRTseq methylome data. An active RM system methylates 100% of its target motifs in the genome, 60 because unmethylated motifs are substrates for the cognate REase, which introduces chromosomal breaks 61 resulting in bacterial cell death (28, 29). Therefore, allowing for a small margin of incomplete post-62 replicative methylation in actively dividing cells during DNA isolation, we assume that motifs that are 63 methylated >95% indicate an active RM system ( Fig. 2A) . Second, we use REBASE analysis (SI Materials 64 and Methods) to confirm suspected orphan MTases as described previously (20). We designate MTases as 65 orphans if we cannot detect an REase gene homolog with the same target site less than 10 genes away from 66 the MTase, based on genomic coordinates (23, 30). Thus, upon completion of the target identification step, 67
we have a concise list of the target sequences of a strain's active RM systems, targets that need to be 68 eliminated from the DNA sequence of the selected genetic tool in silico. 69
Supplementary Text 4: In silico sequence adaptation of a genetic tool 70
The frequency with which an RM target occurs in the DNA sequence of a genetic tool depends on the length 71 and base composition (GC vs AT content) of the target motif. C) where S is C 143 or G ( Fig. 2A) . Plasmid tools propagated in E. coli strains containing the Dcm orphan MTase are methylated 144 at C 5m CWGG motifs, which overlap with the SauUSI target motif (SCNGS) resulting in vulnerability to 145 degradation by this restriction system upon transformation to S. aureus. Therefore, in addition to the fully 146
SyngenicDNA plasmid (pEPSA5SynJE2Dcm-) we generated partially SyngenicDNA plasmids, one that is 147 RM-silent to Type I systems but not to Type IV systems (pEPSA5SynJE2Dcm+) and another that is vice 148 versa (pEPSA5Dcm-) to determine the relative contribution of Type I or Type IV systems to the genetic 149 barrier in S. aureus JE2. This type of experimental approach can be viewed as a 2x2 factorial design, 150 crossing silencing of the Type I systems and silencing of the Type IV system. 151
The original pEPSA5 plasmid propagated in E. coli NEBalpha, a standard Dcm+ laboratory strain, achieved 152 consistently poor transformation efficiencies in our hands (~10 CFU/µg DNA). This plasmid contains 11 153 individual RM target motifs (Type I; n=3, and Type IV; n=8) ( Fig. S6A ). Both system types are known to 154 be actively involved in defense from foreign DNA in S. aureus (7, 38-40). Elimination of only Type I target 155 motifs from the plasmid (pEPSA5SynJE2Dcm+) achieved a 13-fold increase (p= 2.75x10 -13 ) in 156 transformation efficiency. In contrast, elimination of only Type IV system targets, by passaging pEPSA5 157 through the Dcm-deficient strain E. coli ER2796 (pEPSA5Dcm-), achieved a >139-fold increase 158 (p=2.48x10 -69 ) in efficiency. However, when both Type I and Type IV targets were eliminated 159 (pEPSA5SynJE2Dcm-), we observed a supra-multiplicative (rather than an additive) effect on 160 transformation efficiency, with in an increase of ~70,000-fold (p=7.76x10
-306
) compared with the original 161 pEPSA5Dcm+ plasmid (p for interaction=6.98x10 -27 ). The mechanism of this supra-multiplicative effect is 162 not immediately apparent and raises questions for future studies. For example, are there direct interactions 163 between the distinct types of systems? Additionally, comparing the original and the SyngenicDNA pEPSA5 164 plasmids independently of the Type IV system (pEPSA5Dcm-and pEPSA5SynJE2Dcm-) showed that 165 elimination of the three Type I system targets achieved ~500-fold increase (p=<1.0x10
) in efficiency 166 (Fig. 2B) . As demonstrated here, by using system-specific sets of partially RM-silent plasmids, we can 167 detect the relative contributions of different RM systems within a host strain. 168
Supplementary Text 6: RM systems as the major cause of genetic intractability in bacteria. 169
To arrive at our conclusion that RM systems are the major cause of genetic intractability in bacteria; First, 170
we consider the distribution of a genetic defense system to be a crucial factor in its role in genetic 171 intractability overall. RM systems are nearly ubiquitous and are certainly the most widespread of all genetic 172 defense systems; occurring in ~90% of bacterial genomes (80% containing more than one RM system) 173 compared to CRISPR systems (~47%), BREX (Bacteriophage Exclusion) (~10%), Gabija (8.5%), Wadjet 174 (5.6%), Septu (4.1%), Thoeris (4.0%), Hachiman (3.4%), Zorya (3.4%), Druantia (2.6%), Shedu (2.3%), 175
Kiwa (1.8%), Lamassu (1.3%), DISARM (>1%) and Dna Degradation (DND) (>1%) systems (25, 41-44). 176
Secondly, we consider the systems mode-of-action and its likelihood of promiscuity against any given 177 genetic tool in the laboratory. The target recognition motifs of RM systems tend to be short -ranging from 178 4-18 bp in length (but longer motifs generally tolerate sequence degeneracy, i.e. AACN5GTGC where N= 179 any base). In contrast, the target spacers of CRISPR systems tend to be much longer (from 26-72 base pairs 180 in length, and generally do not tolerate sequence degeneracy across the spacer). Accordingly, the frequency 181 with which an RM target will occur is far higher in any given DNA sequence/genetic tool than for a CRISPR 182 spacer, and therefore more effective in general defense against nonself DNA. Unfortunately, the underlying 183 protective mode-of action for the remaining defense systems remain elusive. Some are purported to operate 184 in an analogous manner to RM systems by distinguishing self from nonself DNA using modified vs 185 unmodified targets (BREX, DISARM, DND systems) while others appear to be primarily "anti-phage" 186 systems in that they target general features of bacteriophages replicative cycle (Gabija, Septu, Thoeris, 187
Hachiman, Zorya, Druantia, Shedu, Kiwa, Lamassu) rather than direct DNA degradation of nonself DNA. For each of the remaining known systems we were unable to find more than one study, respectively, which 209 directly examined the role of the defense system on plasmid transformation efficiency. In cases where this 210 analysis was performed, authors often found little to no effect on plasmid transformation, BREX (42) backbone within a multiple cloning site flanked by attB and attP sites (bacterial and phage attachment 5 recognition sites of the øC31 integrase enzyme, red and yellow circles respectively) to form a parental 6 plasmid. The E. coli backbone also contains the antibiotic-selection marker Kan R (blue arrow), a pUC origin 7 (grey box) for high-copy-number autonomous replication in E. coli, and 32x tandem repeats of the I-SceI 8 homing endonuclease recognition site (blue box) for I-SceI targeted degradation after MC induction. The 9 øC31 integrase and I-SceI enzymes are arabinose inducible and encoded on the chromosome of E. coli 10 ZYCY10P3S2T (1). (B) In our repurposed bacterial MC strategy, a functional bacterial replicon/genetic 11 tool takes the place of the eukaryotic transgene cassette. This allows for high-yield production of 12 minimalistic genetic tools, which lack an E. coli replicon, for application in bacteria other than E. coli. We 13 used the S. aureus replicon of the pEPSA5 plasmid to form a pEPSA5 minicircle that is 38% smaller than 14 pEPSA5. pRRSDamET; where ET is editing template). These plasmids were used to amplify each MTase editing template prior to λ-Red recombineering. 42 Figure S4 . The CRISPR-Cas9/λ-Red recombineering scheme used in E. coli MC (ZYCY10P3S2T) for scarless MTase gene deletion. pTarget 43 plasmids (pT-Dcm and pT-Hsd) each encode constitutively expressed gRNAs for Cas9-mediated targeting of MTase genes in unsuccessfully edited 44 cells. gRNA sequences used are included in Table S5 . 45 isolated from E. coli strains MC, JMC1, JMC2 and JMC3. Genoic DNA from the methyl-deficient E.coli ER2796 (NEB) is included as control.
53
DpnI is a methyl-directed endonuclease that requires G m6 ATC for activity. JMC3 gDNA is resistant to DpnI cleavage indicating it is unmethylated 54 at Dam (GATC) sites. 55 Figure S6 . Schematic of pEPSA5 plasmid with S. aureus JE2 RM targets and construction of 56 pEPSA5SynJE2. (A) Forsyth and colleagues described the original pEPSA5 S. aureus-E. coli shuttle 57 vector (3). This plasmid contains 11 individual S. aureus JE2 RM target motifs (Type I; n=3, and Type IV; 58 n=8) that will be recognized and targeted for degradation upon transformation. (B) We assembled 59 pEPSA5SynJE2 by replacing a 3-kbp fragment of pEPSA5 that contained three JE2 RM target motifs with 60 a de novo synthesized RM-silent fragment. Black arrows indicate JE2 RM target motifs. Red arrows 61 indicate those modified sites on the RM-silent fragment. Red letters indicate modified nucleotides. Type 62 IV system targets are not shown, as these can be eliminated by propagation in a Dcm-deficient E. coli host.
63
Both plasmids are 6850 bp in length and differed by only six nucleotides (99.91% nucleotide identity). 64 amplified to remove the original E. coli replicon. The S. aureus replicon was spliced to the pMC plasmid 67 to form the pEPSA5 parental plasmid, which was transformed into competent E. coli JMC1 cells followed 68 by arabinose induction of MC assembly. pEPSA5MC has a single JE2 RM system target. (B) This process 69 was repeated for pEPSA5SynJE2, which is RM-silent with respect to JE2. pEPSA5MC and 70 pEPSA5SynJE2MC plasmids differ by only the two nucleotides shown in red letters. 71 Figure S8 . Approaches to overcome RM system-mediated genetic barriers in bacteria [adapted from(4)]. Current approaches modify the 72 methylation pattern of a genetic tool, either in vitro or ex vivo, to match that of the desired host to achieve mimicry by methylation. In contrast, 73
SyngenicDNA methods evade RM systems by eliminating their target recognition sequences from DNA to create minimalistic RM-silent genetic 74 tools, and achieve stealth-by-engineering during transformation. 75 a The modified base within each motif is bolded while the modified base in the complementary strand is italicized. b The total number includes motifs occurring on the "+" and "-" strands. were processed and mapped to respective reference sequences using the BLASR mapper 28 (https://github.com/PacificBiosciences/blasr) and the Pacific Biosciences' SMRTAnalysis pipeline 29 (https://www.pacb.com/documentation/smrt-pipe-reference-guide/) using the standard mapping protocol.
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30
Interpulse durations were measured and processed for all pulses aligned to each position in the reference 31 sequence. To identify modified positions, we used Pacific Biosciences' SMRTanalysis v2.3.0 patch 5, 32 which uses an in silico kinetic reference and a t-test-based kinetic score detection of modified base 33 positions. Using SMRTseq data, RM system identification was performed essentially as previously 34 described (3), using the SEQWARE computer resource, a BLAST-based software module in combination 35 with the curated restriction enzyme database (REBASE) (4). Prediction was supported by sequence 36 similarity, presence, and order of predictive functional motifs, in addition to the known genomic context 37 and characteristics of empirically characterized R-M system genes within REBASE and enabled the reliable 38 assignment of candidate methyltransferase genes to each specificity based on their RM types. 39 DNA sequence analysis and manipulation was performed using the Seqbuilder and 
DNA synthesis and assembly of SyngenicDNA plasmids 49
A SyngenicDNA-variant of the pEPSA5 plasmid (pEPSA5Syn) was assembled by replacing a 3.05 kb 50 fragment of the original plasmid, encompassing three JE2 RM target sites, with a de novo synthesized DNA 51 fragment that was RM-silent with respect to S. aureus JE2 (Fig. 2, Fig. S7 ). Primers used are listed in Table  52 S5. The original pEPSA5 plasmid was used as the amplification template for the unmodified backbone, 53 while the plasmid pKan-Frag (Synbio Technologies) was used to amplify the modified RM-silent fragment.
54
PCR amplicons were treated with DpnI to digest non-amplified template DNA and the pEPSA5SynJE2 55 plasmid was assembled using Gibson cloning. Plasmid nucleotide integrity was confirmed by resequencing.
56
The pEPSA5 and pEPSA5SynJE2 plasmids were propagated within E. coli NEBalpha (dam+, dcm+, 57 hsdM+) to produce methylated plasmid DNA or E. coli ER2796 (dam-, dcm-, hsdM-) to produce 58 methylation-free plasmid DNA for evasion of Type IV RM systems. Methylation status of plasmid DNA 59 was confirmed by DpnI treatment and agarose gel electrophoresis whereby only methylated plasmids were 60 subject to digestion. 61
Constructing an anhydrotetracycline inducible CRISPR-Cas9/λ-Red gene editing system 62
We utilized a CRISPR-Cas9/λ-Red multigene editing strategy to introduce scarless MTase gene deletions 63
in the E. coli MC strain (ZYCY10P3S2T). This strategy, initially described (5) by Jiang et al., uses a two-64 plasmid system, pCas and pTarget (Fig. S3A) . In the original system, the pCas plasmid maintains a 65 constitutively expressed cas9 gene and an arabinose-inducible regulatory promoter/repressor module (araC-66 Pbad) controlling the λ-Red system (Gam, Beta, Exo), both present on a temperature sensitive replicon 67 (repA101Ts). The compatible pTarget plasmid has a sgRNA scaffold for the desired Cas9-target under 68 control of the constitutive promoter (J23119) and a pMB1 origin of replication. 69
However, since MC formation within the E. coli MC strain is also regulated by chromosomally integrated 70 araC-Pbad modules, arabinose induction of λ-Red recombination using the original system would cause 71 unintentional induction of MC-assembly enzymes (the ΦC31 integrase and I-SceI homing endonuclease) 72 during gene editing. To avoid this, we replaced the arabinose-inducible module of the λ-Red system with 73 an alternative tetracycline-inducible module. Primers utilized are listed in Table S5 . A 1318-bp region of 74 pCas, upstream of the λ-Red gam gene, containing the araC-Pbad module was replaced with 818-bp 75 tetracycline-inducible regulatory promoter/repressor unit (TetR/PtetO) (Fig. S3B) . The plasmid pCKTRBS 76 served as template DNA for amplification of the TetR/PtetO module, which was spliced to an 11.3-kb 77 amplicon of pCas (lacking the arabinose module) using Gibson assembly to form pCasTet-λ. The modified 78 pCasTet-λ plasmid, in combination with the original pTarget, allowed for CRISPR-Cas9/λ-Red 79 recombineering using anhydrotetracycline, a derivative of tetracycline that exhibits no antibiotic activity, 80 instead of arabinose as an inducer molecule. 81
